Literature DB >> 31043912

Resolution of Severe Gastric Dysmotility Disorder With Acupuncture.

Eleni Pellazgu, Michael M Rothkopf.   

Abstract

BACKGROUND: Patients with severe gastric dysmotility disorder (SGDD) often require parenteral nutrition or jejunostomy feeding. They frequently need long-life gastrostomy drainage tubes for gastric discharge and decompression. Currently few medical options exist for postoperative management. We were recently surprised by the beneficial effect of acupuncture in a case of SGDD, which we present herein. CASE
PRESENTATION: The case involved a 68-y-old male who presented with a diagnosis of malignant pancreatic neoplasm for which he had a recent Whipple procedure. He had persistent nausea and vomiting, postoperative abscesses, and high nasogastric tube output. He was assessed to have SGDD, which required discharge on home total parenteral nutrition (TPN) and gastrostomy drainage. Manual acupuncture at the stomach meridian (ST-36) was performed on postdischarge, day 30. His stomach capacity returned to normal, and he eventually returned to a regular diet consistency and volume. His weight and nutritional parameters remained stable and he was weaned off TPN soon after.
CONCLUSION: Acupuncture of the appropriate stomach meridian may be an important modality for patients with SGDD. This case demonstrates the benefits of considering integrative approach in treatment of gastrointestinal conditions.

Entities:  

Year:  2018        PMID: 31043912      PMCID: PMC6469462     

Source DB:  PubMed          Journal:  Integr Med (Encinitas)        ISSN: 1546-993X


  2 in total

1.  Acupuncture for symptomatic relief of gastroparesis in a diabetic haemodialysis patient.

Authors:  Kun Hyung Kim; Tae-Hun Kim; Jun-Yong Choi; Jong-In Kim; Myeong Soo Lee; Sun Mi Choi
Journal:  Acupunct Med       Date:  2010-05-13       Impact factor: 2.267

Review 2.  Acupuncture for gastrointestinal and hepatobiliary disorders.

Authors:  D L Diehl
Journal:  J Altern Complement Med       Date:  1999-02       Impact factor: 2.579

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.